drugset / Trial / NCT00192244
Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live, Cold-Adapted (CAIV-T) in Healthy Children
Phase 3
Completed
3000 enrolled
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer · collab
RandomizedSingle-groupDouble-blindPrevention
Summary
\- The purpose of this study is to determine the efficacy of CAIV-T in a diverse Asian population aged from 6 months to less than 36 months, in tropical and temperate climates, against culture-confirmed influenza illness. In addition, the trial provides the opportunity to investigate the efficacy of CAIV-T over multiple influenza seasons, and to investigate the effect of CAIV-T on acute otitis media.
Timeline
- Start
- 2000-09
- Primary completion
- —
- Completion
- 2002-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FluMist | Vaccine | — | — |
Indications
No indication recorded.